How to Read a COA: Ensuring 99% Purity in Your Materials

In the world of peptide research, the Certificate of Analysis (COA) is your most important document. It is the molecular fingerprint of your material, providing the empirical proof of identity and purity. Researchers who have not yet established a reconstitution protocol should also review our step-by-step peptide reconstitution guide, as net peptide content directly affects concentration calculations. However, a common mistake in the 2026 research community is conflating “99% Purity” with “100% Peptide.” To ensure the integrity of your study, you must be able to interpret the HPLC chromatogram for purity and the Mass Spectrometry (MS) report for identity. Furthermore, understanding the distinction between Peptide Purity and Net Peptide Content is essential for accurate molar calculations in the lab.

1. HPLC: Verifying Chromatographic Purity

High-Performance Liquid Chromatography (HPLC) is used to determine the purity of the peptide. It measures the ratio of the target peptide peak to the total area of all detected peaks at a specific wavelength (usually 210–220 nm).

1. The Main Peak: In a high-quality 99% pure sample, the primary peak should be sharp and symmetrical.
2. The “Noise”: Small humps or “shoulders” around the main peak represent synthesis by-products, such as deletion sequences (missing an amino acid) or truncated peptides.
3. Why it matters: Even a 2% impurity can introduce unwanted biological variables into your research, potentially skewing results in sensitive signaling assays.

2. Mass Spectrometry (MS): Confirming Identity

While HPLC tells you how pure the substance is, Mass Spectrometry tells you exactly what the substance is.

1. Theoretical vs. Found Mass: Every peptide has a calculated molecular weight (Theoretical Mass). The MS report shows the “Found Mass.”
2. The Tolerance: For a peptide to be verified, the Found Mass must match the Theoretical Mass within a very tight margin (typically +/- 1 Dalton). If these numbers don’t match, you are not researching the compound listed on the label.

3. Purity vs. Net Peptide Content (The “Salt Factor”)

This is the most misunderstood aspect of peptide science. Peptide Purity refers to the percentage of the peptidic material that is the correct sequence. However, the vial also contains non-peptidic material, primarily counter-ions (salts) and residual moisture.

• The Reality: A vial with “99% Purity” usually has a Net Peptide Content (NPC) of only 70%–85%. The remaining 15%–30% consists of the salts (like Acetate or TFA) used during the purification process and water absorbed during lyophilization.
• The Calculation: If you need 5mg of actual peptide for an experiment, you must account for the NPC. Performance Peptides Canada provides net peptide content data on every batch-specific COA, available directly on each product page.
  • Equation: Gross Weight (Total Powder) x NPC = Actual Peptide Weight.

Technical Specification Table: 2026 Quality Tiers

The “Janoshik” Standard in Canada

“In our oversight of the Canadian peptide market, we have seen an increase in ‘fake’ COAs documents that are photoshopped or recycled from old batches. At Performance Peptides Canada, we advocate for 3rd Party Verification through independent labs like Janoshik. A legitimate 2026 COA should always include a verifiable batch number or a QR code that links directly to the testing facility’s database to prevent fraud.”

Summary for Researchers

1. Check the Peak: Look for a sharp, tall HPLC peak with minimal ‘shoulders.’
2. Verify the Mass: Ensure the Found Mass matches the sequence’s Theoretical Mass.
3. Calculate NPC: Don’t forget to adjust your concentrations based on the Net Peptide Content, not just the gross powder weight.

References

1. AmbioPharm Technical FAQ: “What data is provided on the Certificate of Analysis (CoA)?”
2. PMC / Journal of Chromatography: “Reference Standards to Support Quality of Synthetic Peptide Therapeutics.”
3. PMC / Journal of Chromatography: “Reference Standards to Support Quality of Synthetic Peptide Therapeutics.”
4. Health Canada (2026): “Analytical Standards for the Verification of Synthetic Research Reagents.”